Clinical Trial Update: A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and effectiveness of Tovinontrine in chronic heart failure with reduced ejection fraction has completed; no results are provided…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Tovinontrine (tovinontrine)

Snippet

Sponsor: Cardurion Pharmaceuticals, Inc. | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: COMPLETED